Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

MTEM

Molecular Templates Inc

May 15 • 04:00PM ET

1.45

Dollar change -0.04
Percentage change -2.68	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-1.56	Insider Own	45.12%	Shs Outstand	5.37M	Perf Week	-9.38%
Market Cap	9.54M	Forward P/E	-	EPS next Y	-3.93	Insider Trans	9.19%	Shs Float	3.61M	Perf Month	-12.65%
Income	-8.12M	PEG	-	EPS next Q	-0.78	Inst Own	41.33%	Short Float	4.68%	Perf Quarter	-60.70%
Sales	57.31M	P/S	0.17	EPS this Y	-80.56%	Inst Trans	-24.34%	Short Ratio	2.26	Perf Half Y	-74.25%
Book/sh	0.78	P/B	1.85	EPS next Y	-20.92%	ROA	-12.22%	Short Interest	0.17M	Perf Year	-77.51%
Cash/sh	1.75	P/C	0.83	EPS next 5Y	3.20%	ROE	-478.86%	52W Range	1.27 - 9.45	Perf YTD	-61.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	34.83%	ROI	-58.22%	52W High	-84.66%	Beta	1.24
Dividend TTM	-	Quick Ratio	0.97	Sales past 5Y	59.75%	Gross Margin	88.17%	52W Low	14.17%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	0.97	EPS Y/Y TTM	93.70%	Oper. Margin	-18.26%	RSI (14)	35.32	Volatility	14.17% 10.76%
Employees	62	Debt/Eq	2.90	Sales Y/Y TTM	190.10%	Profit Margin	-14.18%	Recom	1.00	Target Price	18.00
Option/Short	No / Yes	LT Debt/Eq	2.31	EPS Q/Q	87.48%	Payout	-	Rel Volume	0.75	Prev Close	1.49
Sales Surprise	-9.76%	EPS Surprise	24.74%	Sales Q/Q	168.71%	Earnings	Mar 29 BMO	Avg Volume	74.87K	Price	1.45
SMA20	-8.62%	SMA50	-28.42%	SMA200	-69.39%	Trades		Volume	55,848	Change	-2.68%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-21	Initiated	BofA Securities	Buy	$12
Feb-01-21	Initiated	UBS	Neutral	$13
Sep-08-20	Initiated	Jefferies	Buy	$21
Mar-25-20	Initiated	Stifel	Buy	$19
Feb-27-20	Initiated	Barclays	Overweight	$22
Apr-29-19	Initiated	UBS	Buy	$12
Dec-11-18	Initiated	Oppenheimer	Outperform	$15
Oct-08-18	Initiated	Laidlaw	Buy	$18

Apr-11-24 01:52PM	MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Apr-09-24 08:11AM	Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism (GlobeNewswire) -6.57%
Mar-29-24 08:21AM	Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Mar-28-24 08:11AM	Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement (GlobeNewswire) -5.08%
Mar-04-24 08:11AM	Molecular Templates, Inc. Provides Interim Update (GlobeNewswire)
05:55PM	Loading…
Feb-08-24 05:55PM	Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Nov-13-23 04:11PM	Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-02-23 04:11PM	Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors (GlobeNewswire)
Nov-01-23 04:12PM	Molecular Templates to Participate in Upcoming Investor Conferences (GlobeNewswire) -9.09%
Sep-28-23 04:11PM	Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer (GlobeNewswire)
Aug-25-23 08:50AM	Looking for a Fast-paced Momentum Stock at a Bargain? Consider Molecular Templates Inc. (MTEM) (Zacks)
Aug-11-23 11:22AM	Molecular Templates Announces 1-for-15 Reverse Stock Split (GlobeNewswire)
Aug-10-23 08:08AM	Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Aug-04-23 09:16AM	After layoffs, Molecular Templates overhauls C-suite (American City Business Journals)
Aug-02-23 04:11PM	Molecular Templates Announces Executive Leadership Changes (GlobeNewswire)
06:55AM	Loading…
Jul-20-23 06:55AM	Daily Vickers Top Buyers & Sellers for 07/20/2023 (Argus Research)
Jul-13-23 08:14AM	Molecular Templates Announces Up to $40 Million Private Placement Offering (GlobeNewswire) +8.51%
Jun-16-23 08:56PM	Molecular Templates Announces Debt Payoff and Restructuring (GlobeNewswire) +6.02%
Jun-01-23 07:57AM	Molecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma (GlobeNewswire)
May-26-23 05:10PM	Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-15-23 04:13PM	Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update (GlobeNewswire)
May-04-23 10:00AM	Will Molecular Templates Inc. (MTEM) Report Negative Q1 Earnings? What You Should Know (Zacks) +8.86%
Apr-17-23 08:00AM	Improved Revenues Required Before Molecular Templates, Inc. (NASDAQ:MTEM) Stock's 45% Jump Looks Justified (Simply Wall St.)
Apr-07-23 06:50PM	Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169 (GlobeNewswire)
Mar-30-23 07:25PM	Molecular Templates Inc. (MTEM) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:10PM	Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update (GlobeNewswire)
Mar-09-23 10:02AM	Molecular Templates Announces IND Acceptance by FDA for MT-8421 ETB Program Targeting CTLA-4 (GlobeNewswire) +5.98%
Mar-01-23 04:44PM	Molecular Templates Announces Participation in Upcoming Conferences (GlobeNewswire)
Dec-02-22 05:02PM	Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire) -6.13%
Nov-23-22 04:30PM	Molecular Templates, Inc. to Present Fireside Chats at Two Upcoming Investor Conferences: Evercore ISIs 5th Annual HealthCONx Conference and Piper Sandlers 34th Annual Healthcare Conference (GlobeNewswire)
07:39AM	Loading…
Nov-13-22 07:39AM	Molecular Templates Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-10-22 05:55PM	Molecular Templates Inc. (MTEM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:15PM	Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-04-22 11:00AM	Molecular Templates, Inc. to Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancers (SITC) 37th Annual Meeting (GlobeNewswire)
Aug-31-22 04:52PM	Molecular Templates Announces Participation in Four Upcoming Conferences (GlobeNewswire)
Aug-17-22 06:17AM	Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2022 (Simply Wall St.)
Aug-11-22 04:10PM	Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-08-22 10:00AM	Field Trip Health Ltd. (FTRP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Aug-04-22 10:00AM	Molecular Templates Inc. (MTEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jun-06-22 08:00AM	Molecular Templates Presentations at the 2022 ASCO Annual Meeting Demonstrate Advancement in PD-L1 and HER2 Programs (GlobeNewswire) -5.01%
May-17-22 04:05PM	Molecular Templates to Present at Upcoming Investor Conferences (GlobeNewswire)
May-12-22 04:30PM	Molecular Templates, Inc. Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-10-22 05:25PM	Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates (Zacks) +8.21%
May-06-22 10:18AM	Rock star Growth Puts Molecular Templates (NASDAQ:MTEM) In A Position To Use Debt (Simply Wall St.) -8.23%
May-05-22 05:55PM	Nektar Therapeutics (NKTR) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -8.14%
03:00PM	Will Molecular Templates Inc. (MTEM) Report Negative Q1 Earnings? What You Should Know (Zacks)
May-04-22 07:25AM	Amneal Pharmaceuticals (AMRX) Q1 Earnings Meet Estimates (Zacks)
Apr-12-22 07:30AM	Molecular Templates Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach (GlobeNewswire)
Apr-08-22 08:00AM	Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors (GlobeNewswire) -5.18%
Mar-28-22 04:30PM	Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results (GlobeNewswire)
Mar-18-22 12:39PM	Investors in Molecular Templates (NASDAQ:MTEM) have unfortunately lost 77% over the last year (Simply Wall St.)
Mar-02-22 08:00AM	Molecular Templates Strengthens Board of Directors and Management Team (GlobeNewswire)
Mar-01-22 08:00AM	Molecular Templates to Present at the Upcoming Investor Conferences (GlobeNewswire)
Jan-17-22 07:08AM	Is Molecular Templates, Inc. (NASDAQ:MTEM) Popular Amongst Institutions? (Simply Wall St.)
Nov-30-21 05:30PM	Molecular Templates Provides Corporate Update and Outlines 2022 Milestones (GlobeNewswire)
Nov-18-21 08:00AM	Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402 (GlobeNewswire) -5.08%
Nov-16-21 09:06AM	Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way? (Simply Wall St.) -7.06%
Nov-15-21 12:25PM	Molecular Templates Inc. (MTEM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-28-21 03:05PM	Molecular Templates Inc. (MTEM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
12:31PM	Zacks Industry Outlook Highlights: Xencor, Enanta, Catalyst Pharmaceuticals, and Molecular Templates (Zacks)
Oct-12-21 09:08AM	Wall Street Analysts Predict a 98% Upside in Molecular Templates Inc. (MTEM): Here's What You Should Know (Zacks)
Sep-22-21 03:24AM	Molecular Templates Inc. (MTEM) Moves 11.8% Higher: Will This Strength Last? (Zacks)
Sep-20-21 08:00AM	Molecular Templates to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (GlobeNewswire)
Sep-14-21 12:09PM	2 Strong Buy Stocks Trading at Steep Discounts (TipRanks)
Aug-12-21 08:05PM	Molecular Templates Inc. (MTEM) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:30PM	Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Aug-05-21 10:50AM	10 Best Biotech Stocks to Buy According to Alan Fraziers Frazier Healthcare Partners (Insider Monkey)
Jul-29-21 03:05PM	Molecular Templates Inc. (MTEM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Jul-21-21 03:20PM	Molecular Templates, Inc. (MTEM) Fell Out Of Favor With Hedge Funds? (Insider Monkey)
Jul-19-21 05:27AM	Here's What Molecular Templates, Inc.'s (NASDAQ:MTEM) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Jul-09-21 08:00AM	Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors (GlobeNewswire)
Jul-06-21 08:00AM	Molecular Templates to Present at the Ladenburg Thalmann 2021 Healthcare Conference (GlobeNewswire)
Jun-30-21 08:30AM	Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors (GlobeNewswire)
May-18-21 03:04AM	Analysts Are More Bearish On Molecular Templates, Inc. (NASDAQ:MTEM) Than They Used To Be (Simply Wall St.)
May-13-21 07:50PM	Molecular Templates Inc. (MTEM) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:30PM	Molecular Templates, Inc. Reports First Quarter 2021 Financial Results (GlobeNewswire)
Apr-20-21 11:36AM	Insider Buying Of Molecular Templates Stock Corresponds With Analyst Ratings (SmarterAnalyst)
Apr-12-21 07:00AM	Molecular Templates Announces Poster Presentations on its Engineered Toxin Bodies at the American Association of Cancer Research (AACR) Virtual Annual Meeting I (GlobeNewswire)
Apr-05-21 04:12PM	Why Molecular Templates Stock Crashed Today (Motley Fool) -23.55%
11:48AM	Molecular Templates Stock Falls After It Stops MT-3724 Development In Hematological Malignancies (Benzinga)
07:00AM	Molecular Templates to Prioritize Next-Generation ETB Candidates (GlobeNewswire)
Mar-21-21 03:37AM	Upgrade: Analysts Just Made A Dazzling Increase To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts (Simply Wall St.)
Mar-18-21 04:30PM	Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results (GlobeNewswire)
Feb-26-21 08:00AM	Molecular Templates to Participate in Upcoming Virtual Investor Conferences (GlobeNewswire)
Feb-21-21 03:02AM	Newsflash: Molecular Templates, Inc. (NASDAQ:MTEM) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.)
Feb-18-21 07:30AM	Molecular Templates, Inc. Announces Pricing of $75.9 Million Public Equity Offering (GlobeNewswire) -7.49%
Feb-17-21 04:05PM	Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-11-21 09:13AM	Molecular Templates Shares Jump On Research Pact With Bristol-Myers In Cancer Settings (Benzinga) +8.74%
07:30AM	Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer (GlobeNewswire)
Feb-08-21 06:20AM	Investors Who Bought Molecular Templates (NASDAQ:MTEM) Shares Three Years Ago Are Now Up 41% (Simply Wall St.)
Jan-19-21 08:00AM	Molecular Templates Announces FDA Acceptance of IND Application for MT-6402, a PD-L1-Targeted Engineered Toxin Body Enabled with Proprietary Antigen Seeding Technology (GlobeNewswire) +6.70%
Dec-21-20 04:30PM	Molecular Templates, Inc. Provides Update on MT-5111 Phase 1 Study (GlobeNewswire)
Dec-18-20 10:21PM	Is MTEM A Good Stock To Buy Now According To Hedge Funds? (Insider Monkey)
Nov-30-20 09:54PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (GlobeNewswire)
Nov-28-20 11:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (ACCESSWIRE)
Nov-25-20 10:10PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (GlobeNewswire)
Nov-23-20 11:15PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (ACCESSWIRE)
Nov-21-20 11:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (GlobeNewswire)
Nov-18-20 10:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM (ACCESSWIRE) -5.58%

Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariepy, and Leigh Revers in 2001 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BIOTECH TARGET N V	10% Owner	Apr 02 '24	Buy	2.35	250,000	587,500	1,279,820	Apr 04 08:13 PM
BIOTECH TARGET N V	10% Owner	Jul 17 '23	Buy	0.47	4,255,319	2,000,000	15,447,322	Jul 19 03:14 PM

Open in Screener

MGNX

Macrogenics Inc

May 15 • 04:00PM ET

4.71

Dollar change +0.26
Percentage change 5.84	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM VTWO VHT IBB IWN SCHA LABU IWO

Index	RUT	P/E	-	EPS (ttm)	-0.38	Insider Own	6.45%	Shs Outstand	62.07M	Perf Week	-67.87%
Market Cap	294.99M	Forward P/E	-	EPS next Y	-1.89	Insider Trans	-6.77%	Shs Float	58.59M	Perf Month	-71.76%
Income	-23.24M	PEG	-	EPS next Q	-0.70	Inst Own	93.92%	Short Float	17.01%	Perf Quarter	-72.50%
Sales	43.36M	P/S	6.80	EPS this Y	-1850.91%	Inst Trans	-8.39%	Short Ratio	4.15	Perf Half Y	-26.06%
Book/sh	1.70	P/B	2.78	EPS next Y	35.59%	ROA	-7.85%	Short Interest	9.96M	Perf Year	-27.76%
Cash/sh	2.94	P/C	1.60	EPS next 5Y	-	ROE	-21.58%	52W Range	3.14 - 21.88	Perf YTD	-51.04%
Dividend Est.	-	P/FCF	-	EPS past 5Y	48.88%	ROI	-17.08%	52W High	-78.47%	Beta	2.04
Dividend TTM	-	Quick Ratio	3.61	Sales past 5Y	15.77%	Gross Margin	64.67%	52W Low	50.00%	ATR (14)	1.64
Dividend Ex-Date	-	Current Ratio	3.63	EPS Y/Y TTM	75.19%	Oper. Margin	-423.39%	RSI (14)	22.77	Volatility	24.75% 10.55%
Employees	339	Debt/Eq	0.32	Sales Y/Y TTM	-73.78%	Profit Margin	-53.60%	Recom	1.75	Target Price	13.90
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	-36.25%	Payout	-	Rel Volume	1.48	Prev Close	4.45
Sales Surprise	-38.74%	EPS Surprise	-30.72%	Sales Q/Q	-62.83%	Earnings	May 09 AMC	Avg Volume	2.40M	Price	4.71
SMA20	-65.62%	SMA50	-69.54%	SMA200	-54.10%	Trades		Volume	3,560,587	Change	5.84%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-10-24	Downgrade	Stifel	Buy → Hold	$29 → $7
May-10-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$24 → $8
Apr-26-24	Initiated	B. Riley Securities	Buy	$25
Apr-09-24	Upgrade	TD Cowen	Hold → Buy
Mar-04-24	Reiterated	BTIG Research	Buy	$12 → $24
Feb-14-24	Downgrade	H.C. Wainwright	Buy → Neutral	$12 → $14
Dec-20-23	Upgrade	Citigroup	Neutral → Buy	$7 → $13
Nov-07-23	Upgrade	Guggenheim	Neutral → Buy	$12
Mar-17-23	Downgrade	Guggenheim	Buy → Neutral
Nov-22-22	Downgrade	Cowen	Outperform → Market Perform
Nov-14-22	Upgrade	BMO Capital Markets	Market Perform → Outperform	$5.70 → $16
Jul-18-22	Downgrade	SMBC Nikko	Outperform → Neutral	$5
Jul-11-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$31 → $4
May-04-22	Downgrade	Guggenheim	Buy → Neutral
Feb-28-22	Upgrade	Citigroup	Neutral → Buy	$23 → $21
Feb-11-22	Initiated	BMO Capital Markets	Outperform	$31
Feb-04-22	Initiated	SMBC Nikko	Outperform	$40
Nov-17-21	Resumed	Guggenheim	Buy	$30
Oct-19-21	Initiated	JMP Securities	Mkt Outperform	$39

Show Previous Ratings

May-13-24 12:30PM	MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman (GlobeNewswire) +32.33%
07:30AM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-24 06:01PM	MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman (GlobeNewswire) -77.44%
04:51PM	Macrogenics Stock Drops 77% After Study Deaths (The Wall Street Journal)
03:29PM	Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ... (GuruFocus.com)
03:17PM	Loading…
03:17PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:01PM	Top Midday Decliners (MT Newswires)
08:35AM	Why Is Macrogenics (MGNX) Stock Down 69% Today? (InvestorPlace)
07:48AM	Top Premarket Decliners (MT Newswires)
07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
07:15AM	BMO Downgrades MacroGenics to Market Perform From Outperform, Price Target at $8 (MT Newswires)
07:14AM	Stifel Downgrades MacroGenics to Hold (MT Newswires)
07:12AM	TD Cowen Downgrades MacroGenics to Hold From Buy (MT Newswires)
07:12AM	MacroGenics Says Five Patients Died in Cancer Study (MT Newswires)
06:02AM	MacroGenics' stock crashes after 5 deaths seen in ADC trial (FierceBiotech.com)
04:57AM	Loading…
04:57AM	MacroGenics Q1 Loss Widens, Revenue Falls (MT Newswires)
02:15AM	MacroGenics (MGNX) Q1 2024 Earnings Call Transcript (Motley Fool)
May-09-24 08:57PM	MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:10PM	MacroGenics: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data (GlobeNewswire)
May-03-24 07:30AM	MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call (GlobeNewswire)
May-01-24 10:05AM	Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 (PR Newswire) +5.21%
Apr-26-24 08:00AM	B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target (MT Newswires)
Apr-03-24 04:30PM	MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures (GlobeNewswire)
Mar-14-24 08:18AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 07:19AM	Q4 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents) -15.02%
12:30AM	MacroGenics (MGNX) Q4 2023 Earnings Call Transcript (Motley Fool)
Mar-07-24 10:42PM	Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ... (GuruFocus.com)
09:55PM	MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023 (InvestorPlace)
05:30PM	Loading…
05:30PM	MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:01PM	MacroGenics Provides Update on Corporate Progress and 2023 Financial Results (GlobeNewswire)
Mar-06-24 11:29PM	Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX) (GuruFocus.com)
Mar-01-24 05:48PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.24%
Feb-29-24 10:00AM	Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-27-24 05:45PM	MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Feb-02-24 04:30PM	MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire)
07:19AM	MacroGenics (MGNX) Surges 6.8%: Is This an Indication of Further Gains? (Zacks)
Jan-15-24 04:51PM	The 3 Most Undervalued Biotech Stocks to Buy in January (InvestorPlace)
Jan-08-24 04:30PM	MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire) +7.57%
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Nov-07-23 10:56AM	Q3 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents) +17.10%
08:59AM	MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript (Insider Monkey)
01:15AM	MacroGenics (MGNX) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-06-23 05:12PM	Macrogenics Inc (MGNX) Reports Q3 2023 Earnings: Net Income of $17. ... (GuruFocus.com)
04:27PM	MacroGenics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-23 04:30PM	MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Sep-05-23 07:00AM	MacroGenics Announces Achievement of $15 Million Milestone Related to Gileads Nomination of a Bispecific Research Program (GlobeNewswire)
Aug-31-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-19-23 07:40AM	3 Under-the-Radar Biotech Stocks to Buy in 2023 (Motley Fool)
Aug-14-23 11:19AM	MacroGenics' (MGNX) Shares Jump 19% in One Week: Here's Why (Zacks) -6.24%
Aug-11-23 01:26PM	MacroGenics, Inc. (NASDAQ:MGNX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 12:33PM	Why Shares of MacroGenics Are Jumping Thursday (Motley Fool) +24.30%
07:01AM	Q2 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 11:30PM	MacroGenics (MGNX) Q2 2023 Earnings Call Transcript (Motley Fool)
05:50PM	MacroGenics (MGNX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:52PM	MacroGenics: Q2 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 05:35PM	MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Jul-05-23 11:55AM	MacroGenics (NASDAQ:MGNX) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Jun-28-23 08:12AM	AdaptHealth Corp. (AHCO) Soars 19.6%: Is Further Upside Left in the Stock? (Zacks)
Jun-08-23 07:27AM	MacroGenics Insider Confidence Rewarded, Stock Hits US$321m Market Cap \ (Simply Wall St.)
May-14-23 08:09AM	These Analysts Just Made An Incredible Downgrade To Their MacroGenics, Inc. (NASDAQ:MGNX) EPS Forecasts (Simply Wall St.)
May-10-23 12:10PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2023 Earnings Call Transcript (Insider Monkey)
12:30AM	MacroGenics (MGNX) Q1 2023 Earnings Call Transcript (Motley Fool)
May-09-23 05:25PM	MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:21PM	MacroGenics: Q1 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results (GlobeNewswire)
May-05-23 08:27AM	MacroGenics, Inc.'s (NASDAQ:MGNX) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
May-04-23 04:30PM	MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Apr-25-23 10:01AM	MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
Apr-24-23 06:15PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-07-23 08:48AM	Here's Why We're Not Too Worried About MacroGenics' (NASDAQ:MGNX) Cash Burn Situation (Simply Wall St.)
Mar-22-23 01:22PM	MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ (retifanlimab-dlwr) (GlobeNewswire) -5.76%
Mar-20-23 06:59PM	Why MacroGenics Stock Inched Higher on Monday (Motley Fool)
Mar-18-23 02:52AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-17-23 06:15PM	Why MacroGenics Stock Tumbled Today (Motley Fool)
Mar-16-23 12:17PM	Why Shares of MacroGenics Climbed Thursday (Motley Fool) +10.25%
07:10AM	Q4 2022 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 11:00PM	MacroGenics (MGNX) Q4 2022 Earnings Call Transcript (Motley Fool)
05:35PM	MacroGenics (MGNX) Surpasses Q4 Earnings Estimates (Zacks)
04:01PM	MacroGenics Provides Corporate Update and 2022 Financial Results (GlobeNewswire)
Mar-14-23 12:32PM	Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi (Zacks) +9.69%
08:00AM	Synaffix Announces Expansion of ADC Collaboration with MacroGenics (PR Newswire)
Mar-11-23 07:30AM	Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher (Simply Wall St.)
Mar-09-23 03:59PM	Why Shares of MacroGenics Jumped Thursday (Motley Fool) +12.18%
Mar-08-23 05:36PM	MacroGenics Announces Sale of TZIELD Royalty Interest for up to $200 Million (GlobeNewswire) -6.30%
Mar-07-23 06:00PM	MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Mar-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-20-23 09:56AM	Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength? (Zacks)
Feb-17-23 06:27AM	Daily Vickers Top Buyers & Sellers for 02/17/2023 (Argus Research) +25.67%
Feb-14-23 10:01AM	MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients (Benzinga) -17.48%
Feb-13-23 05:20PM	MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium (GlobeNewswire) +15.25%
Feb-06-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-23 07:57AM	SurModics (SRDX) Surges 6.1%: Is This an Indication of Further Gains? (Zacks) +6.13%
06:48AM	Daily Vickers Top Buyers & Sellers for 01/24/2023 (Argus Research)
Jan-06-23 06:15PM	MacroGenics (MGNX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-04-23 05:50PM	MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Peters Jeffrey Stuart	Senior VP and General Counsel	Apr 04 '24	Option Exercise	4.82	42,500	204,850	51,395	Apr 08 06:07 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Apr 04 '24	Sale	15.55	51,395	799,148	0	Apr 08 06:07 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Mar 06 '24	Option Exercise	10.90	19,625	213,875	28,520	Mar 08 04:14 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Mar 06 '24	Sale	21.50	19,625	421,938	8,895	Mar 08 04:14 PM
Risser Eric Blasius	Chief Operating Officer	Mar 04 '24	Option Exercise	10.15	15,000	152,250	80,059	Mar 06 04:20 PM
Spitznagel Thomas	Sr VP, Technical Ops	Mar 04 '24	Option Exercise	11.50	10,000	115,000	18,316	Mar 06 04:19 PM
Risser Eric Blasius	Chief Operating Officer	Mar 04 '24	Sale	19.76	41,159	813,501	38,900	Mar 06 04:20 PM
Karrels James	SVP, CFO and Secretary	Mar 04 '24	Sale	20.50	30,000	615,000	171,452	Mar 06 04:18 PM
Spitznagel Thomas	Sr VP, Technical Ops	Mar 04 '24	Sale	20.00	10,000	200,000	8,316	Mar 06 04:19 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 26 '24	Sale	17.22	16,124	277,655	8,895	Feb 28 04:20 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 22 '24	Option Exercise	0.00	26,250	0	35,145	Feb 26 04:27 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 22 '24	Option Exercise	0.00	28,125	0	110,258	Feb 26 04:26 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 15 '24	Option Exercise	0.00	16,670	0	88,004	Feb 20 06:03 PM
Risser Eric Blasius	Chief Operating Officer	Feb 15 '24	Option Exercise	0.00	16,670	0	70,938	Feb 20 06:04 PM
Cilinski Lynn	VP, Controller and Treasurer	Feb 15 '24	Option Exercise	0.00	6,668	0	8,591	Feb 20 06:04 PM
Koenig Scott	President and CEO	Feb 15 '24	Option Exercise	0.00	42,341	0	1,091,977	Feb 20 06:04 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 15 '24	Option Exercise	0.00	13,336	0	13,336	Feb 20 06:05 PM
Spitznagel Thomas	Sr VP, Technical Ops	Feb 15 '24	Option Exercise	0.00	13,336	0	13,336	Feb 20 06:03 PM
Karrels James	SVP, CFO and Secretary	Feb 15 '24	Option Exercise	0.00	15,003	0	206,779	Feb 20 06:04 PM
Eck Stephen L.	Chief Medical Officer	Feb 15 '24	Option Exercise	0.00	16,670	0	16,670	Feb 20 06:41 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 07 '24	Sale	18.00	3,334	60,012	71,334	Feb 07 04:19 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 05 '24	Option Exercise	11.11	76,251	847,355	76,251	Feb 07 04:17 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 05 '24	Sale	16.50	76,251	1,258,142	0	Feb 07 04:17 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 01 '24	Sale	15.00	13,316	199,740	74,668	Feb 02 04:21 PM
Bonvini Ezio	Sr VP, Research & CSO	Jan 19 '24	Sale	12.00	13,316	159,792	87,984	Jan 22 04:57 PM
Bonvini Ezio	Sr VP, Research & CSO	Dec 20 '23	Sale	10.08	18,880	190,310	101,300	Dec 21 04:12 PM
BIOTECH TARGET N V	10% Owner	Oct 02 '23	Buy	4.46	150,000	669,585	9,929,963	Oct 04 03:31 PM
BIOTECH TARGET N V	10% Owner	Sep 07 '23	Buy	5.26	200,000	1,052,840	9,779,963	Sep 11 03:39 PM
HURWITZ EDWARD	Director	Aug 30 '23	Buy	4.91	15,000	73,650	33,074	Sep 01 04:06 PM

Open in Screener

RDUS

Radius Recycling Inc.

May 15 • 04:00PM ET

18.78

Dollar change -0.68
Percentage change -3.49	%

Basic Materials • Steel • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

RDUS Radius Recycling Inc. daily Stock Chart

Held by: VTI VB IWM AVUV VBR VXF FNDA IWN DFAT SCHA

Index	RUT	P/E	-	EPS (ttm)	-2.28	Insider Own	8.89%	Shs Outstand	27.31M	Perf Week	6.58%
Market Cap	525.46M	Forward P/E	21.84	EPS next Y	0.86	Insider Trans	-0.04%	Shs Float	25.49M	Perf Month	7.75%
Income	-64.30M	PEG	-	EPS next Q	-0.45	Inst Own	81.22%	Short Float	3.11%	Perf Quarter	-22.27%
Sales	2.82B	P/S	0.19	EPS this Y	-332.94%	Inst Trans	-4.02%	Short Ratio	3.06	Perf Half Y	-17.52%
Book/sh	30.18	P/B	0.62	EPS next Y	143.43%	ROA	-3.63%	Short Interest	0.79M	Perf Year	-34.06%
Cash/sh	0.48	P/C	38.75	EPS next 5Y	10.00%	ROE	-7.23%	52W Range	16.84 - 36.64	Perf YTD	-37.73%
Dividend Est.	0.75 (3.99%)	P/FCF	-	EPS past 5Y	-	ROI	-4.91%	52W High	-48.74%	Beta	1.66
Dividend TTM	0.75 (3.99%)	Quick Ratio	0.92	Sales past 5Y	8.12%	Gross Margin	9.41%	52W Low	11.52%	ATR (14)	0.87
Dividend Ex-Date	Apr 19, 2024	Current Ratio	1.96	EPS Y/Y TTM	-189.47%	Oper. Margin	0.43%	RSI (14)	51.94	Volatility	3.25% 3.82%
Employees	3353	Debt/Eq	0.58	Sales Y/Y TTM	-13.43%	Profit Margin	-2.28%	Recom	4.00	Target Price	17.00
Option/Short	Yes / Yes	LT Debt/Eq	0.55	EPS Q/Q	-885.14%	Payout	-	Rel Volume	0.65	Prev Close	19.46
Sales Surprise	-0.84%	EPS Surprise	5.02%	Sales Q/Q	-17.84%	Earnings	Apr 04 BMO	Avg Volume	259.31K	Price	18.78
SMA20	3.62%	SMA50	-0.15%	SMA200	-25.52%	Trades		Volume	168,234	Change	-3.49%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-24	Downgrade	Seaport Research Partners	Neutral → Sell	$17.50
Dec-14-23	Initiated	Seaport Research Partners	Neutral
May-19-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-24-22	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$58
Jul-19-21	Initiated	Northland Capital	Outperform	$80
Apr-09-21	Initiated	Goldman	Buy	$48
Jan-12-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-20-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$28
Oct-10-19	Reiterated	Cowen	Market Perform	$22 → $21
Sep-23-19	Downgrade	Goldman	Neutral → Sell	$27 → $23
Jun-25-19	Reiterated	Cowen	Market Perform	$24 → $25
Jan-14-19	Downgrade	Goldman	Buy → Neutral
Jan-09-19	Initiated	Cowen	Market Perform	$24
Aug-15-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Mar-20-18	Initiated	Goldman	Buy	$42
Sep-07-17	Initiated	Macquarie	Neutral
Apr-01-16	Reiterated	DA Davidson	Neutral	$15 → $18
Nov-24-15	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jul-01-15	Upgrade	BofA/Merrill	Underperform → Buy
Jan-05-15	Downgrade	DA Davidson	Buy → Neutral	$34 → $25

Show Previous Ratings

Apr-16-24 09:00AM	Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ACCESSWIRE)
Apr-08-24 09:10AM	Radius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Apr-05-24 05:48PM	Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ... (GuruFocus.com)
Apr-04-24 09:31AM	Radius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 Results (GuruFocus.com)
08:00AM	Radius Recycling Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
10:58AM	Loading…
Mar-18-24 10:58AM	15 Biggest Steel Companies in the US (Insider Monkey) -7.86%
Mar-14-24 04:35PM	Second Quarter Fiscal 2024 Preliminary Results and Announcement of Earnings Date (GlobeNewswire)
Mar-09-24 07:48AM	5 Best Steel Stocks to Buy According to Analysts (Insider Monkey)
Mar-04-24 08:30AM	Radius Recycling Named One of the 2024 Worlds Most Ethical Companies (Business Wire) -5.00%
Jan-06-24 08:07AM	Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript (Insider Monkey)
Jan-05-24 01:20AM	Q1 2024 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-04-24 03:06PM	Schnitzer Steel Industries Inc (RDUS) Faces Market Headwinds in Q1 Fiscal 2024 (GuruFocus.com) -7.69%
08:17AM	Schnitzer Steel: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Radius Recycling Reports First Quarter Fiscal 2024 Financial Results (Business Wire)
Dec-18-23 09:00AM	Radius Recycling Announces First Quarter Fiscal 2024 Earnings Date and Webcast Details (Business Wire)
09:15AM	Loading…
Dec-13-23 09:15AM	Radius Recycling Publishes Fiscal Year 2023 Sustainability Report (Business Wire)
Nov-16-23 08:30AM	Radius Recycling Executive Included on TIME100 Climate List of the 100 Most Influential Leaders Driving Business Climate Action (Business Wire)
Oct-26-23 10:01AM	Radius Health, Inc. (NASDAQ:RDUS) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:25AM	Q4 2023 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 09:43AM	Schnitzer Steel Industries Inc (RDUS) Reports Q4 and Fiscal 2023 Financial Results (GuruFocus.com)
08:26AM	Schnitzer Steel: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
08:00AM	Radius Recycling Reports Fourth Quarter and Fiscal 2023 Financial Results (Business Wire)
Sep-29-23 08:30AM	Radius Recycling Announces Fourth Quarter and Fiscal 2023 Earnings Date and Webcast Details (Business Wire)
Aug-30-23 08:00AM	Radius Recycling Announces Ticker Symbol Change (Business Wire)
Aug-10-23 05:31PM	Exclusive: A public company CEO on spending millions in Portland, making a risky name change (American City Business Journals)
Jul-26-23 05:45PM	Schnitzer Steel, after 117 years, renames itself (American City Business Journals)
04:00PM	Schnitzer Steel Rebrands as Radius Recycling to Reflect Companys Vision, Purpose, and Impact on Circular Economy (Business Wire)
Jul-04-23 07:33AM	Schnitzer Steel (SCHN) Q3 Earnings & Revenues Miss Estimates (Zacks)
Jun-30-23 12:48PM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:12AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
07:29AM	Loading…
Jun-29-23 07:29AM	Steel Stock Worthington Signals Breakout On Earnings Beat, Upbeat Outlook (Investor's Business Daily)
Jun-28-23 04:43PM	Steel Stock Worthington Jumps Near Buy Point As Earnings Beat; SCHN Falls (Investor's Business Daily)
04:13PM	Steel Stock Worthington Tests Buy Point With Earnings Due; SCHN Falls (Investor's Business Daily)
03:30PM	Steel Stock Worthington Tops Buy Point With Earnings Due; SCHN Falls (Investor's Business Daily)
02:18AM	Q3 2023 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-27-23 04:09PM	Steel Stock SCHN Falls On Mixed Quarterly Financials As Profits Drop 74% (Investor's Business Daily)
08:13AM	Schnitzer Steel: Fiscal Q3 Earnings Snapshot (AP Finance)
08:00AM	Schnitzer Reports Third Quarter Fiscal 2023 Financial Results (Business Wire)
Jun-26-23 04:07PM	Steel Stocks Flirt With Buy Points Ahead Of Earnings As Weak Demand In China Stunts Pricing (Investor's Business Daily)
Jun-23-23 06:46PM	Stock Market Action Plan: Nike, Micron, Carnival Earnings And The Bud Light Beer Wars (Investor's Business Daily)
03:01PM	Nike Faces Inventory Questions Ahead Of Earnings Report; Schnitzer Steel Offers Options Trade Idea (Investor's Business Daily)
Jun-21-23 08:45AM	Schnitzer Steel Named to TIME's List of 100 Most Influential Companies (Business Wire)
Jun-18-23 10:02AM	Schnitzer Steel Industries, Inc.'s (NASDAQ:SCHN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? (Simply Wall St.)
Jun-12-23 08:30AM	Schnitzer Announces Third Quarter Fiscal 2023 Earnings Date and Conference Call Webcast Details (Business Wire)
Jun-03-23 09:01AM	Investing in Schnitzer Steel Industries (NASDAQ:SCHN) three years ago would have delivered you a 84% gain (Simply Wall St.)
May-19-23 09:20AM	With 84% ownership, Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) boasts of strong institutional backing (Simply Wall St.)
May-05-23 08:41AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Reinvesting At Lower Rates Of Return (Simply Wall St.)
Apr-14-23 09:30AM	Schnitzer Steel (SCHN) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Apr-10-23 08:45AM	Schnitzer Steel (SCHN) Earnings and Revenues Down Y/Y in Q2 (Zacks)
Apr-08-23 08:20AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of $0.1875 (Simply Wall St.)
Apr-07-23 12:22AM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Apr-05-23 08:21AM	Schnitzer Steel: Fiscal Q2 Earnings Snapshot (AP Finance) -5.37%
08:00AM	Schnitzer Reports Second Quarter Fiscal 2023 Financial Results (Business Wire)
Mar-28-23 09:40AM	Should Value Investors Buy Schnitzer Steel Industries (SCHN) Stock? (Zacks)
Mar-20-23 06:00PM	Schnitzer Steel (SCHN) Outpaces Stock Market Gains: What You Should Know (Zacks)
05:00PM	Schnitzer Announces Second Quarter Fiscal 2023 Earnings Date (Business Wire)
Mar-16-23 08:34AM	Estimating The Intrinsic Value Of Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) (Simply Wall St.)
Mar-13-23 07:00AM	Schnitzer Named One of the 2023 Worlds Most Ethical Companies (Business Wire)
Mar-10-23 06:00PM	Schnitzer Steel (SCHN) Gains As Market Dips: What You Should Know (Zacks)
Feb-28-23 06:00PM	Schnitzer Steel (SCHN) Stock Moves -0.03%: What You Should Know (Zacks)
Feb-22-23 06:00PM	Schnitzer Steel (SCHN) Flat As Market Sinks: What You Should Know (Zacks)
Feb-14-23 06:00PM	Schnitzer Steel (SCHN) Gains As Market Dips: What You Should Know (Zacks)
Jan-30-23 02:38PM	7 of the Most Highly Rated ESG Companies to Invest in Now (InvestorPlace)
Jan-22-23 07:19AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
Jan-18-23 07:30AM	Schnitzer Steel Named Most Sustainable Company in the World by Corporate Knights (Business Wire)
01:03AM	Steel recycler beats wind firm to become world's most sustainable company (Reuters)
Jan-10-23 06:50AM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q1 2023 Earnings Call Transcript (Insider Monkey) +9.26%
Jan-09-23 07:18AM	Schnitzer Steel Industries First Quarter 2023 Earnings: US$0.64 loss per share (vs US$1.64 profit in 1Q 2022) (Simply Wall St.)
Jan-08-23 07:17AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
Jan-05-23 08:00AM	Schnitzer Reports First Quarter Fiscal 2023 Financial Results (Business Wire)
Jan-03-23 09:40AM	Are Investors Undervaluing Schnitzer Steel Industries (SCHN) Right Now? (Zacks)
Jan-02-23 05:53AM	Schnitzer Steel Industries, Inc.'s (NASDAQ:SCHN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Dec-29-22 10:00AM	Analysts Estimate Schnitzer Steel (SCHN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Dec-26-22 09:40AM	Are Investors Undervaluing Aperam (APEMY) Right Now? (Zacks)
Dec-19-22 04:30PM	First Quarter Fiscal 2023 Preliminary Results and Announcement of Earnings Date (Business Wire)
Dec-16-22 07:29AM	Schnitzer Steel Industries' (NASDAQ:SCHN) investors will be pleased with their notable 60% return over the last three years (Simply Wall St.)
Dec-15-22 08:30AM	Schnitzer Steel Highlights Achievements on People, Planet, and Profit Goals in Its Fiscal Year 2022 Sustainability Report (Business Wire)
Dec-12-22 10:24AM	11 Best Steel Stocks To Buy Today (Insider Monkey)
Nov-25-22 01:42PM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.)
Nov-16-22 10:25AM	11 Biggest Garbage Companies in the US (Insider Monkey)
Nov-14-22 08:30AM	Schnitzer Steel Industries, Inc. Appoints Gregory R. Friedman to its Board of Directors (Business Wire)
Nov-05-22 08:19AM	Here's What We Like About Schnitzer Steel Industries' (NASDAQ:SCHN) Upcoming Dividend (Simply Wall St.)
Oct-27-22 06:41AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of $0.1875 (Simply Wall St.) -5.89%
Oct-24-22 08:00AM	Schnitzer Reports Fourth Quarter and Fiscal 2022 Financial Results (Business Wire)
Oct-20-22 10:02AM	Analysts Estimate United States Steel (X) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-17-22 10:00AM	Analysts Estimate Schnitzer Steel (SCHN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-12-22 09:00AM	Schnitzer Steel Recertified as a Great Place to Work® (Business Wire)
08:26AM	The Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Analysts Have Been Trimming Their Sales Forecasts (Simply Wall St.)
Oct-07-22 07:58AM	Does This Valuation Of Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Imply Investors Are Overpaying? (Simply Wall St.)
Oct-04-22 06:30PM	Fourth Quarter and Fiscal 2022 Preliminary Results and Announcement of Earnings Date (Business Wire)
Aug-01-22 06:17PM	Schnitzer Steel appoints new CFO, shifting of financial team roles (American City Business Journals)
08:30AM	Schnitzer Steel Expands Role of Chief Strategy Officer and Appoints New Chief Financial Officer (Business Wire)
Jul-20-22 08:56AM	Could The Market Be Wrong About Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Given Its Attractive Financial Prospects? (Simply Wall St.)
Jul-07-22 08:54AM	Implied Volatility Surging for Schnitzer Steel (SCHN) Stock Options (Zacks) +7.09%
Jul-02-22 08:18AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of US$0.19 (Simply Wall St.)
Jun-29-22 10:01AM	Schnitzer Steel shares advance on earnings (MarketWatch)
09:15AM	Schnitzer Steel (SCHN) Tops Q3 Earnings and Revenue Estimates (Zacks)
08:00AM	Schnitzer Reports Third Quarter Fiscal 2022 Financial Results (Business Wire)
Jun-24-22 09:33AM	Top 10 Stock Picks of Randall Smiths Alden Global (Insider Monkey)
Jun-14-22 03:32PM	Schnitzer Steel Industries' (NASDAQ:SCHN) five-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)

Radius Recycling, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company was founded by Sam Schnitzer in 1906 and is headquartered in Portland, OR.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gaggini Stefano R.	SVP, CFO	May 06 '24	Sale	18.57	1,021	18,960	76,255	May 07 03:43 PM
Souza Brian	SVP, Chief Ops Mgmt Officer	Nov 10 '23	Sale	23.49	4,500	105,705	18,767	Nov 14 07:13 PM
Heiskell Steven	SVP & President, Recycling P&S	Nov 07 '23	Sale	24.14	8,000	193,120	136,367	Nov 08 06:50 PM
Vaughn James Matthew	SVP, GC, CCO, Corp. Secretary	Nov 06 '23	Sale	24.83	571	14,178	6,608	Nov 07 01:42 PM
Gaggini Stefano R.	SVP, CFO	Nov 03 '23	Sale	24.86	7,269	180,707	63,295	Nov 07 01:35 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MTEM

Molecular Templates Inc

MGNX

Macrogenics Inc

RDUS

Radius Recycling Inc.

Upgrade your FINVIZ experience